CLINICAL_TRIALS
trial_result
· 2016-11-02
Clinical Trial Update: A Study of RO5045337 in Patients With Solid Tumors [Phase 1]
Summary
Phase 1 clinical trial assessing RO5045337 in patients with solid tumors has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 1 | Status: COMPLETED